Real-world effectiveness of dual blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA study)

Autores: Gónzalez-Santiago, S. (Autor de correspondencia); Saura, C.; Ciruelos, E.; Alonso, J. L.; de la Morena, P.; Santisteban Eslava, Marta; Gallegos Sancho, M. L.; de Luna, A.; Dalmau, E.; Servitja, S.; Ruiz Borrego, M.; Chacón, J. I.